Please visit our sponsors

Rolclub does not endorse ads. Please see our disclaimer.
Page 10 of 12 FirstFirst ... 89101112 LastLast
Results 91 to 100 of 114
  1. #91
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Canadian cannabis stocks continue to grow on Tilray's financials
    The majority of Canada's biggest cannabis producers experienced strong price growth this Wednesday after Tilray (TLRY) reported better than expected Q1 sales growth. According to its quarterly report, the company's sales totaled CAD 23 million, which constitutes a rise of 195% compared with a year ago.
    In addition to the above, Tilray also announced that it plans to start purchasing cannabis from third-party producers but is yet to find a supplier capable of satisfying its quality requirements.
    The market was unshaken even by Aurora Cannabis's (ACB) quarterly report, which revealed worse than expected Q1 sales. As the company itself noted, its net sales for that period totaled CAD 65.1 million, which represents a 20% increase on the previous quarter. Nevertheless, investors had expected that figure to be more in the region of CAD $68.7 million. Meanwhile, the company reported a net loss of CAD $160.2 million, which represents and improvement on last quarter.


    Our financial scouts predict that Tilray's most recent quarterly report will give Canadian cannabis stocks the boost they need to continue their current growth. With this mind, they are forecasting share price increases for all the major producers, with Aurora Cannabis, Tilray and Canopy Growth (CGC) set to rise to $8.5-9, $49.5 and $46 respectively. Meanwhile, they see Aphria (APHA) and Cronos (CRON) up to $7.5 and "$15.5 respectively.

  2. #92
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    European markets weigh up May’s resignation.
    European investors are still assessing the medium-to-short term implications of British PM Theresa May’s announcement that she will be stepping down come 7 June. The current favourite in the race for Number 10 is former Foreign Minister Boris Johnson. Market insiders believe that May’s resignation could help speed up the process of the government securing cross-party support for any final EU withdrawal plan. This comes at a time when the risk of a “no deal” Brexit is looming increasingly large with each day that passes. Elsewhere, European investors are also concerned that May's departure will make it difficult for the Bank of England to maintain its high base rate policy, thus increasing the likelihood of a reduction. Another key area of interest is the still-unresolved US-China trade conflict, which has only been intensifying of late. Despite US President Donald Trump's statement that the US's allegations of irregularities against Chinese company Huawei can be resolved by way of a trade deal, investors are still worried that the parties will be unable to reach any kind of agreement. The next meeting between the two countries' respective heads of state is set to take place as part of the G20 meeting in Japan next month. In regional corporate news, we have received reports that a Renault and Fiat Chrysler merger could be on the cards. In fact, the two companies are allegedly discussing the terms of the potential fifty-fifty merger as we speak.

  3. #93
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    European markets under negative pressure from all sides


    The European stock markets are under intense pressure from a whole raft of negative factors, both internal and external. For instance, the prospects of a resolution to the US-China trade conflict remain hazy at best, which is negatively impacting the entire world economy. This comes after China made a statement that it would be prepared to limit rare earth metal exports to the US in response to US restrictions on Chinese exports. Another worry weighing on Europe's indices is Italy's budget. Investors fear that the European Commission might fine Italy 3.5 billion euros in light of its national debt situation. The EU has announced that it strongly recommends Italy reassess its budget stance, claiming that the country's decision to increase its deficit has only harmed the Mediterranean nation's economy, which now has the slowest growth rate in the region. And who could forget Brexit? Britain's departure from the EU still remains one of the biggest challenges facing the European markets. The issue has seen a political dogfight emerge in the UK in which the Brexit Party — which wants Brexit at any cost — seems to have come out on top. This comes as a number of political powers are predicting that a no deal Brexit would have serious negative consequences for both the British and EU economies.

  4. #94
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Hexo’s worse-than-expected Q3 report pushes down cannabis stocks


    Canadian cannabis stocks were down significantly on Friday after Hexo announced lower Q3 sales compared to last quarter.
    According to the company’s own data, its gross cannabis sales totaled approximately $12 million, which represents a decline compared with Q2. This news was not well received by investors and it only served to intensify their concerns over the industry’s future prospects.
    In light of this development, many are now doubtful of Hexo’s ability to reach their planned sales growth target of $400 million by 2020. Following its poor quarterly report, Hexo’s share price fell by 8%, driving down shares in other companies in the sector (with an average fall of 4-5%).
    Our financial scouts’ short-term prediction is that the market will continue to reel from Hexo’s weak report, which means a further decline in Canadian cannabis stocks is on the cards.
    With this in mind, they predict that shares in Canopy Growth (CGC) could fall to $41, with Aurora Cannabis (ACB) potentially sliding to $7. Meanwhile, they see Aphria (APHA), Tilray (TLRY) and Cronos (CRON) down to $6, $40 and $16 respectively.
    Mitt Lemaev, financial scout at Libertex.

  5. #95
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    European investors await Fed rate decision


    The upcoming two-day meeting of the US Federal Reserve is at the forefront of European investors’ minds this week amid strong expectation that the regulator will keep rates at their current level of 2.25-2.5%. Investors are also keen to hear the Fed’s rate forecast, with many predicting a majority of the bank’s board will argue in favour of a July reduction in light of the deteriorating world economy. Elsewhere, European markets are still weighing up the prospects of a no deal Brexit as the UK’s internal political turmoil continues. Former Foreign Minister and bookies’ favourite for PM Boris Johnson has stated that the UK will not pay the country’s 39 billion Brexit bill until the EU agrees to a deal that is acceptable to Britain. This comes after current PM Theresa May officially stepped down as leader of the Conservative Party. She has pledged to stay on as the country’s Prime Minister until her successor has been chosen. The name of the new head of government is expected to be made public at some point during the second half of July. In regional news, one positive development for European markets was the announcement from international ratings agency Fitch that it has affirmed France's Long-Term Foreign-Currency Issuer Default Rating (IDR) at “AA” with stable outlook. According to the agency, the country’s rating is supported by its big, strong and diversified economy, its robust, effective civil and social institutions, as well as its record of macroeconomic stability.


    Andrey Voytkiv, Financial Scout at Libertex

  6. #96
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Where to buy and sell Slack shares? The new instrument is now available in Libertex


    Libertex just expanded its trading portfolio launching CFD (contracts for difference) for shares of Slack Inc. (WORK). This provides Libertex users with new trading opportunities.


    Traders are not only able to use Slack as one of the most popular messengers worldwide, but they trade CFD on its shares too! Slack is an attractive instrument for both short term traders and long-term investors.


    Slack made a direct listing at June 20th. Slack became the third “unicorn” company, after Lyft and Pinterest, that started offering its shares in the past months. All three companies are available at Libertex.


    Trade Slack now with Libertex!


    About Libertex:


    Libertex is an international brand with a twenty year history in the financial markets and online commerce. Libertex provides investors with access to trading stocks, currencies, indices, commodities, gold, oil, gas and many other financial instruments. The Libertex team has more than 2,200,000 customers in Latin America, Europe and Asia owing to its first-class service. Libertex has more than 200 commercial instruments. In 2016, Libertex was recognized by the Forex EXPO Awards as the best trading platform; and the Global Banking and Finance Review named it the best trading application in the EAEU. In 2017-2018, Libertex was announced as Best trading application and Best cryptocurrency broker by Forex Awards...

  7. #97
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Canadian cannabis stocks are set to rise
    Canadian cannabis stocks are set to rise on positive news from Aleafia Health Inc. that it is about to finish paying off convertible bonds in the amount of $25 million.
    This comes after shares in Canopy Growth (CGC) saw significant growth following reports that the company had come to an agreement to acquire Acreage Holdings Inc. Under the terms of the deal, Canopy will be able to take control of the company as soon as US federal laws on cannabis are relaxed. Acreage will continue to operate independently but will have access to Canopy's intellectual property, branding, product recipes and patents.
    Nevertheless, there were also some negative developments for the market, with Governor of New Hampshire Chris Sununu vetoing a bill that would open up governmental medical cannabis to commercial enterprises. This bit of news came as a serious setback to entrepreneurs who were hoping to set up businesses were the bill to have been passed.
    Our financial scouts believe that the Canadian cannabis market is likely to rebound from this recent positive corporate news wave. With this in mind, they see share price rises for all of the major producers in this sector, with Canopy Growth, Aurora Cannabis (ACB) and Tilray (TLRY) tipped to rise to $42-43, $8-8.5 and $47 respectively. Elsewhere, they predict Aphria (APHA) will rise to

  8. #98
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Cannabis stocks up as Aurora Cannabis receives new licenses
    Shares in major cannabis producers are largely up this Wednesday on news that market leader Aurora Cannabis (ACB) has been granted licenses for two new outdoor cultivation sites.
    This comes after a period of decline for the sector following a disappointing quarterly report from Organigram. At a time when all the experts were predicting a 3 cent per share rise, the company posted a 7 cent per share loss and a net pre-tax income increase of 628% to CAD 24.75.
    Nevertheless, Organigram's executive management is convinced that it will be able to improve its financials some time during the latter part of the year. Finally, we end our coverage of Organigram with information that the company is planning to add another 100 employees to its already 700-strong workforce.


    In other news, Aurora Cannabis's share price rose following the announcement that it had been granted licenses by Health Canada for two new open-air cultivation facilities in Quebec and British Columbia. The company has stated that the new sites will be used for cultivation research to develop new technology, genetics and intellectual property for outdoor production. Aurora Cannabis went on to clarify that it deliberately selected open-air sites since this would enable it to research methods of cultivation for different climactic conditions.
    According to our financial scouts, cannabis stocks should continue to rise for as long as this latest wave of positive market sentiment lasts. With this in mind, they see share price increases for all the major producers, with Canopy Growth (CGC) rising to $36.00 and Aurora Cannabis up to $8.00. Meanwhile, they predict that shares in Tilray (TLRY), Aphria (APHA) and Cronos (CRON) could jump to $45.00, $6.50 and $15.00 respectively.

  9. #99
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Cannabis stocks trading mixed on contradictory news


    Canadian cannabis stocks are trading mixed this Wednesday in a trend that has persisted since the beginning of the week when CannTrust's share price lost a further 5% following another scandal, this time involving one of its Ontario stores. This comes after the Canadian authorities announced that a probe of CannTrust's operations had revealed that the company was cultivating cannabis in unlicensed rooms at its Pelham, Ontario site. In an effort to draw a line under this scandal, the company dismissed two members of its executive management team who, it is alleged, were aware of the violation but failed to take action to halt the unlicensed production activities.
    Now the company is looking at a variety of potential solutions to the challenges it is facing including selling the business outright.
    In other news, some cannabis stocks received a boost in the form of reports that US company MedMen has become a major supplier of cannabis to the Californian market, boasting 17 retail locations in the state.
    Elsewhere, shares in Aurora Cannabis (ACB) fell after the company announced it had completed its $47.7 million acquisition of Hempco Food and Fibre Inc. Following the deal, Hempco will become part of the Canadian giant's Aurora Hemp arm whose focus will be the production of hemp-derived products.


    Our financial scouts believe that, as long as the news atmosphere remains contradictory, the cannabis market will continue to trade mixed. As such, they see shares in Canopy Growth (CG) up to $28.00, with Aurora Cannabis and Aphria (APHA) also rising to $6.50 and $7.00 respectively. Meanwhile, they predict potential share price drops for Tilray (TLRY) and Cronos (CRON) to $28.50 and $11.50 respectively.

  10. #100
    Senior Member Libertex's Avatar
    Join Date
    Jul 2017
    Posts
    201
    Feedback Score
    0
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Cannabis stocks trading mixed on contradictory news


    Canadian cannabis stocks are trading mixed this Wednesday in a trend that has persisted since the beginning of the week when CannTrust's share price lost a further 5% following another scandal, this time involving one of its Ontario stores. This comes after the Canadian authorities announced that a probe of CannTrust's operations had revealed that the company was cultivating cannabis in unlicensed rooms at its Pelham, Ontario site. In an effort to draw a line under this scandal, the company dismissed two members of its executive management team who, it is alleged, were aware of the violation but failed to take action to halt the unlicensed production activities.
    Now the company is looking at a variety of potential solutions to the challenges it is facing including selling the business outright.
    In other news, some cannabis stocks received a boost in the form of reports that US company MedMen has become a major supplier of cannabis to the Californian market, boasting 17 retail locations in the state.
    Elsewhere, shares in Aurora Cannabis (ACB) fell after the company announced it had completed its $47.7 million acquisition of Hempco Food and Fibre Inc. Following the deal, Hempco will become part of the Canadian giant's Aurora Hemp arm whose focus will be the production of hemp-derived products.


    Our financial scouts believe that, as long as the news atmosphere remains contradictory, the cannabis market will continue to trade mixed. As such, they see shares in Canopy Growth (CG) up to $28.00, with Aurora Cannabis and Aphria (APHA) also rising to $6.50 and $7.00 respectively. Meanwhile, they predict potential share price drops for Tilray (TLRY) and Cronos (CRON) to $28.50 and $11.50 respectively.

  11. Sponsored Links
Page 10 of 12 FirstFirst ... 89101112 LastLast

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Share |